| Literature DB >> 25830893 |
Sandra Schoors1,2, Ulrike Bruning1,2, Rindert Missiaen1,2, Karla Cs Queiroz1,2, Gitte Borgers1,2, Ilaria Elia3,4, Annalisa Zecchin1,2, Anna Rita Cantelmo1,2, Stefan Christen3,4, Jermaine Goveia1,2, Ward Heggermont5, Lucica Goddé1,2, Stefan Vinckier1,2, Paul P Van Veldhoven6, Guy Eelen1,2, Luc Schoonjans1,2, Holger Gerhardt7,8,9, Mieke Dewerchin1,2, Myriam Baes10, Katrien De Bock1,2,11, Bart Ghesquière1,2, Sophia Y Lunt12, Sarah-Maria Fendt3,4, Peter Carmeliet1,2.
Abstract
The metabolism of endothelial cells during vessel sprouting remains poorly studied. Here we report that endothelial loss of CPT1A, a rate-limiting enzyme of fatty acid oxidation (FAO), causes vascular sprouting defects due to impaired proliferation, not migration, of human and murine endothelial cells. Reduction of FAO in endothelial cells did not cause energy depletion or disturb redox homeostasis, but impaired de novo nucleotide synthesis for DNA replication. Isotope labelling studies in control endothelial cells showed that fatty acid carbons substantially replenished the Krebs cycle, and were incorporated into aspartate (a nucleotide precursor), uridine monophosphate (a precursor of pyrimidine nucleoside triphosphates) and DNA. CPT1A silencing reduced these processes and depleted endothelial cell stores of aspartate and deoxyribonucleoside triphosphates. Acetate (metabolized to acetyl-CoA, thereby substituting for the depleted FAO-derived acetyl-CoA) or a nucleoside mix rescued the phenotype of CPT1A-silenced endothelial cells. Finally, CPT1 blockade inhibited pathological ocular angiogenesis in mice, suggesting a novel strategy for blocking angiogenesis.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25830893 PMCID: PMC4413024 DOI: 10.1038/nature14362
Source DB: PubMed Journal: Nature ISSN: 0028-0836 Impact factor: 49.962